National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) clinical trials
Listed in the registry as: U.S. National Institutes of Health.
The registry lists 100 studies whose lead sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 100. Browse all 100 →
- Natural History and Development of SpondyloarthritisRecruitingNCT01422694
- Pain Phenotyping of Rheumatic Diseases - An Observational StudyNot yet recruitingNCT07829497
- Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic VasculitisRecruitingNCT02257866
- Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsRecruitingNCT03510442
- Studies of the Natural History of Rheumatic DiseasesRecruitingNCT00024479
- Study of Systemic Lupus ErythematosusRecruitingNCT00001372
- Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic DiseaseRecruitingNCT02504879
- Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 2
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by QuestionnairesRecruitingNCT05567198
- Natural History of Inflammatory Muscle DiseasesRecruitingNCT05738824
- Studies of Dermatologic Diseases Biospecimen Acquisition ProtocolRecruitingNCT02471352
- The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVDRecruitingNCT05440422Phase 2
- Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisCompletedNCT00059748
- Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune DiseasesCompletedNCT04690816
- A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of PhototoxicityCompletedNCT00353158Phase 1
- Frequency and Complications of Major Orthopedic Procedures in Medicare BeneficiariesActive, not recruitingNCT02281747
- The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic DiseasesCompletedNCT00001505
- Natural History and Pathogenesis of Alopecia in Children and AdultsCompletedNCT05502796
- Progression of Spinal Fusion in Ankylosing SpondylitisCompletedNCT00085995
- Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal StudyCompletedNCT00056719
- Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWithdrawnNCT07012057Phase 2
- Evaluation and Treatment of Patients With Dermatologic DiseasesCompletedNCT00001506
- A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or LupusWithdrawnNCT06238531Phase 1
- Genomic Effects of Glucocorticoids in Patients With Systemic Lupus ErythematosusCompletedNCT04233164Early Phase 1
- Study and Treatment of Inflammatory Muscle DiseasesCompletedNCT00001265
- National Registry for Ichthyosis and Related DisordersCompletedNCT00074685
- Juvenile Rheumatoid Arthritis Research RegistryCompletedNCT00090571
- Scleroderma RegistryCompletedNCT00074568
- Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD)TerminatedNCT03395340Phase 2
- Omalizumab for LupusCompletedNCT01716312Phase 1
- Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)CompletedNCT02338999Phase 1/2
- Genetic Basis of Primary ImmunodeficienciesTerminatedNCT00001788
- Anakinra for Inflammatory Pustular Skin DiseasesCompletedNCT01794117Phase 2
- Study of Arthritis and Related ConditionsCompletedNCT00006333
- Osteoarthritis Initiative (OAI): A Knee Health StudyCompletedNCT00080171
- Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy VolunteersTerminatedNCT00031174
- Genetic Determinants of Ankylosing Spondylitis SeverityCompletedNCT00056849
- Clinically Important Changes in Rheumatoid ArthritisCompletedNCT00056602
- Insulin Resistance and Atherosclerosis in Women With LupusCompletedNCT00544102
- Monoclonal Antibody Treatment for Systemic Lupus ErythematosusCompletedNCT00046774Phase 1
- Infliximab (Remicade ) to Treat Dermatomyositis and PolymyositisCompletedNCT00033891Phase 2
- Impact of Exercise on Older Persons With OsteoarthritisCompletedNCT00000434Phase 2
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus ErythematosusCompletedNCT02535689Phase 1
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's ArteritisCompletedNCT00556439Phase 2
- Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)CompletedNCT01801449Phase 2
- Genetics of Rheumatoid ArthritisCompletedNCT00001678
- Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) StudyCompletedNCT01360099
- A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's DiseaseWithdrawnNCT01211977Phase 1/2
- Anakinra for Behcet s DiseaseCompletedNCT01441076Phase 1/2
- Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory DiseaseTerminatedNCT00069329Phase 1/2